Novel Therapeutic Options for Acute Lymphoblastic Leukemia
This webcast is co-provided by Cancernet, LLC and A. Webb Roberts Center for CME of Baylor Scott & White Health.
For more information visit: www.cancernetus.net
Ariad Pharmaceuticals, Inc
Scroll to the Bottom of this Information to Begin this Course
Release date: July 21, 2016
Valid through: July 21, 2017
Estimated Time to Complete Activity: 1.0 hour (60 min)
CME Provider contact information: To contact CME provider, call 214 820 2317
A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 214-820-2317.
This webcast is designed to meet the educational needs of hematologists/oncologists and other health care professionals who diagnose, treat, and manage patients with acute lymphoblastic leukemia.
Statement of Need/Program Overview
This webcast is intended to improve care of patients with acute lymphoblastic leukemia by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Upon completion of this activity, participants should be better able to:
- Describe the alterations in cytogenetic, molecular abnormalities, NOTCH1, CRLF2 mutations, epigenetic markers in the diagnosis and treatment of patients with acute lymphoblastic leukemia (ALL)
- Evaluate the novel therapeutic options for relapsed/refractory Philadelphia-positive and Philadelphia-negative patients with ALL
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Elias Jabbour, MD
Department of Leukemia,
Division of Cancer Medicine,
The University of Texas MD Anderson Cancer Center,
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the co-providership of MedNet, LLC and A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health. The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the ACCME to provide continuing medical education for physicians.
The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: BMS, Ariad, Pfizer, Amgen
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: BMS, Ariad, Pfizer, Amgen
- No relevant financial relationships
All other individuals in a position to control content have no relevant financial relationships to disclose.
Course Viewing Requirements
Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this webcast. During the period July 21, 2016 through July 21, 2017, participants must read all of the material and study the educational webcast.
Instructions for Participation and Credit
This webcast includes text, graphics, and may include multimedia features. There are no fees for participating in or receiving credit for this webcast.
Click on all of the "medical education webcast" links and review the content presented. You must view all of the content to proceed to the post-test.
Read, complete, and submit answers to the post-test questions and evaluation questions online. You must answer all missed questions until you get them correct.
Participants must receive a test score of 100% in order to proceed to the course evaluation, and they must respond to all evaluation questions to receive a letter of credit.
If needed, you may save your answers and return to complete your course at a later date. You can find your saved course by selecting "Your Course History" on the left navigation bar. Then select "View" next to the course you would like to complete.
Letter Of Credit & Transcripts
After submitting the webcast evaluation, you may access your letter of credit by selecting "Your Certificates" on the left navigation bar.
Select "Credit" to view letters of credit onscreen and print from your browser. You may print the letter of credit, but you may not alter the letter of credit.
Your credits will be tallied and may be viewed by selecting "View your transcripts" in the "Your Account" area
Hardware and Software Requirements
Recommends version 6.x browsers or higher from Microsoft or Netscape. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of content. These activities will be marked as such and will provide links to the required software. Required software may include:
Windows Media Player
RealNetworks RealOne Player
VLC Media Player